SEELOS THERAPEUTICS INC (SEEL) Stock Income Statement
USA - NASDAQ:SEEL - US81577F3073 - Common Stock
1.28 USD
-1.17 (-47.76%)
1.45 USD
+0.17 (+13.28%)
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.01M | 2.20M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 31.82M | 42.70M | 70.92M | 61.67M | 18.76M | |||
| Research and Development | 20.43M | 30.12M | 58.62M | 46.65M | 10.98M | |||
| Selling, General, and Administrative Expenses | 11.39M | 12.59M | 12.30M | 15.02M | 7.78M | |||
| Operating Income | -29.81M | -40.50M | -70.92M | -61.67M | -18.76M | |||
| Interest Income/Expense | -49.00K | 123.00K | 107.00K | -1.85M | -119.00K | |||
| Other Income/Expense | 39.07M | 11.64M | -2.73M | -287.00K | -223.00K | |||
| Non Recurring Items | -5.12M | -9.15M | 0.00 | -2.24M | N/A | |||
| Income Before Taxes | 4.09M | -37.88M | -73.53M | -66.05M | -19.10M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | 4.09M | -37.88M | -73.53M | -66.05M | -19.10M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 9.76 | -61.85 | -165.97 | -174.42 | -102.41 | |||
| Non GAAP EPS | N/A | -45.32 | -10.83 | -0.75 | -0.44 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | 203.13% | -1719.56% | N/A | N/A | N/A | |||
| Operating Profit Margin | -1480.04% | -1838.36% | N/A | N/A | N/A | |||
All data in USD